BCY-18469

N/A

Report date: 2025/06/11 11:06:54

Base Information

Drug NameBCY-18469
Drug Alias NameN/A
ClassificationBiologicsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionEphrin type-A receptor 2 antagonistsAnticancer protein kinase inhibitors
TargetsEphrin type-A receptor 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGerman Cancer Research Center (Dkfz)
China Registration ClassN/A

Develop Information

Active CompaniesBicycle Tx LtdGerman Cancer Research Center (Dkfz)
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A